GL1X · GenesisL1 explorer

Research workbench

Crystal structure of E253Q bmrr bound to 22 base pair promoter site

Analyse Crystal structure of E253Q bmrr bound to 22 base pair promoter site in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3D71
Type
protein + DNA
Length
300 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bmr promoter DNA; Multidrug-efflux transporter 1 regulator
UniProt
P39075
Ligands
ZN
Pockets
3 · best druggability 0.58

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
MBmr promoter DNAdna23——
AMultidrug-efflux transporter 1 regulatorprotein27740% helix, 23% strandP39075

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A
  • IMD · Imidazole · additive · 5 copies · chains A
  • PGO · S-1,2-propanediol · additive · 3 copies · chains A
  • FLC · Citrate anion · additive · chains A
  • ETF · Trifluoroethanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11110.580.8526empty
2760.530.8619IMD
31620.530.7920FLC, IMD

Interfaces

1 interface between chains.

  • M–A · 374 Ų buried · 12 hydrogen bonds · protein-nucleic

Compared structures

  • 3D71 · Crystal structure of E253Q BMRR bound to 22 base pair promoter site · the same entry in another collection · chain M against M, TM-score 1.00
  • P39075 · AlphaFold monomer V2.0 prediction for multidrug-efflux transporter 1 regulator (P39075) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.